株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心臓バイオマーカーの世界市場

Global Cardiac Biomarker Market Research and Forecast 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 611063
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。
Back to Top
心臓バイオマーカーの世界市場 Global Cardiac Biomarker Market Research and Forecast 2018-2023
出版日: 2018年01月10日 ページ情報: 英文
概要

当レポートでは、世界の心臓バイオマーカー市場について調査し、市場の概要とセグメント別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 レポートのサマリー

第2章 市場概要と動向

  • 定義
  • アナリストの見解と現在の市場動向
  • 法規制
  • 特許分析

第3章 市場決定因子

  • 促進因子
  • 阻害因子
  • 機会

第4章 市場セグメンテーション

  • タイプ別市場
    • クレアチンキナーゼ
    • トロポニン
    • ミオグロビン
    • ナトリウム利尿ペプチド
    • 虚血修飾アルブミン
    • その他
  • 用途別市場
    • 心筋梗塞
    • 鬱血性心不全
    • 急性冠動脈症候群
    • アテローム性動脈硬化
    • その他
  • 検査場所別市場
    • 試験所検査
    • ポイントオブケア検査

第5章 競合環境

  • 戦略分析
  • 企業分析

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の諸国

第7章 企業プロファイル

  • ABBOTT DIAGNOSTICS
  • ALERE INC.
  • BECTON, DICKSON & CO.
  • BG MEDICINE INC.
  • BIOMERIEUX
  • BIO-RAD LABORATORIES
  • CISBIO BIOASSAYS
  • COVANCE
  • CRITICAL DIAGNOSTICS
  • LIFESIGN
  • LUMINEX CORPORATION
  • RANDOX LABORATORIES LTD.
  • RESPONSE BIOMEDICAL CORPORATION
  • ROCHE HOLDING AG
  • SIEMENS HEALTHCARE
  • SIGNOSIS INC.
  • THERMO FISHER SCIENTIFIC INC.
図表

List of Tables

  • TABLE # 1: GLOBAL CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY GEOGRAPHY , 2017-2023,
  • TABLE # 2: GLOBAL CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY TYPE 2017-2023($ MILLION)
  • TABLE # 3: GLOBAL CREATINE KINASE (CK-MB) MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 4: GLOBAL TROPONINS (T,I) MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 5: GLOBAL MYOGLOBIN MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 6: GLOBAL NATRIURETIC PEPTIDES (BNP-&NT-PROBNP) MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 7: GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 8: GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 9: GLOBAL CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY APPLICATION, 2017-2023, ($ MILLION)
  • TABLE # 10: GLOBAL MYOCARDIAL INFRACTION MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 11: GLOBAL CONGESTIVE HEART FAILURE MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 12: GLOBAL ACUTE CORONARY SYNDROME MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 13: GLOBAL ATHEROSCLEROSIS MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 14: GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 15: GLOBAL CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY LOCATION OF TESTING 2017-2023, ($ MILLION)
  • TABLE # 16: GLOBAL LABORATORY TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 17: GLOBAL POINT OF CARE TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023, ($ MILLION)
  • TABLE # 18: MERGER AND ACQUISITION
  • TABLE # 19: GLOBAL CARDIAC BIOMARKER MARKET, BY GEOGRAPHY 2016-20122($ MILLION)
  • TABLE # 20: NORTH AMERICA CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY TYPE 2017-2023 ($MILLION)
  • TABLE # 21: NORTH AMERICA CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023 ($MILLION)
  • TABLE # 22: NORTH AMERICA CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY LOCATION OF TESTING 2017-2023 ($MILLION)
  • TABLE # 23: NORTH AMERICA CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($MILLION)
  • TABLE # 24: EUROPE CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY TYPE 2017-2023 ($MILLION)
  • TABLE # 25: EUROPE CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023 ($MILLION)
  • TABLE # 26: EUROPE CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY LOCATION OF TESTING 2017-2023 ($MILLION)
  • TABLE # 27: EUROPE CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($MILLION)
  • TABLE # 28: ASIA PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY TYPE 2017-2023 ($MILLION)
  • TABLE # 29: ASIA PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023 ($MILLION)
  • TABLE # 30: ASIA PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY LOCATION OF TESTING 2017-2023 ($MILLION)
  • TABLE # 31: ASIA PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY COUNTRIES 2017-2023 ($MILLION)
  • TABLE # 32: REST OF THE WORLD BIOMARKER MARKET RESEARCH AND ANALYSIS, BY TYPE 2017-2023 ($MILLION)
  • TABLE # 33: REST OF THE WORLD CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2017-2023 ($MILLION)
  • TABLE # 34: REST OF THE WORLD CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, BY LOCATION OF TESTING 2017-2023 ($MILLION)

List of Figures

  • FIGURE # 1: GLOBAL CARDIAC BIOMARKER MARKET SHARE, BY TYPE 2017 AND 2023, (IN %)
  • FIGURE # 2: GLOBAL CARDIAC BIOMARKER MARKET SHARE, BY APPLICATION 2017 AND 2023, (IN %)
  • FIGURE # 3: GLOBAL CARDIAC BIOMARKER MARKET SHARE, BY LOCATION OF TESTING 2017 AND 2023, (IN %)
  • FIGURE # 4: GLOBAL CARDIAC BIOMARKER MARKET SHARE, BY GEOGRAPHY 2017 AND 2023, (IN %)
  • FIGURE # 5: NORTH AMERICAN CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 6: US CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 7: CANADA CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 8: EUROPEAN CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 9: UK CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 10: FRANCE MARKET CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 11: GERMANY CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 12: ITALY CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 13: SPAIN CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 14: ROE CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 15: ASIA PACIFIC CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 16: INDIA CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 17: CHINA CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 18: JAPAN CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 19: ROAPAC CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 20: REST OF THE WORLD CARDIAC BIOMARKER MARKET SIZE, 2017-2023 ($MILLION)
目次
Product Code: OMR2017204

The global cardiac biomarker market is anticipated to grow at a CAGR of 7.1% by 2023. There are several drivers that are driving the cardiac biomarker market globally such as rise in the cardiovascular diseases, rise in the geriatric population, and technological development. Rise in the geriatric population and the rise in the cardiac vascular diseases are the major factors that affect the growth of the market as the biomarkers are utilized for detection of the cardiac problems. According to the World Health Organization, in 2015, around17.7 million of people died due to cardio vascular diseases out of these 7.4 million were affected due to coronary heart diseases and an approximately 6.7 million due to heart stroke. The cardiac biomarkers are utilized to detect and measure the risk factor associated with heart diseases. The cardiac biomarkers been successfully tested to provide more accurate prediction of heart failure after chest pain compared to more conventional methods. This is a major factor which may fuel the growth of the market. The market is also affected by technological development of cardiac biomarker.

The cardiac biomarker has been segmented on the basis of by type, by application and by location of testing. By type, the market is bifurcated into Creatine Kinase (CK-MB), troponins (T,I), myoglobin, natriuretic peptides( BNP& NT-proBNP), ischemia modified albumin and others. According to application, the market is bifurcated into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. By location of testing, the market is segmented into Point of care(POC) testing and laboratory testing.

Geographically, the worldwide cardiac biomarker showcase is divided into North America, Europe, Asia-Pacific, and the Rest of the World. Asia Pacific market is considered to be the fastest growing market globally. The rise in the number of cardiovascular patients in the APAC region is considered to rise eventually that enable the cardiac biomarker market to grow. The North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in the technology, support from government, and rise in the key players

The key players in the cardiac biomarker market Include Abbott Diagnostics, Alere Inc., Becton, Dickson & Co., Bg Medicine Inc., Biomerieux, Bio-Rad Laboratories, Cisbio Bioassays, Covance, Critical Diagnostics, Lifesign, Luminex Corporation, Randox laboratories Ltd., Response Biomedical Corporation, Roche Holding Ag, Siemens Healthcare, Signosis Inc., Thermo Fisher Scientific Inc.

MARKET SEGMENTATION:

Global cardiac biomarker market is segmented on the basis of, type, by application, by location of testing and regional outlook.

Global Cardiac Biomarker Market Research and Analysis, By Type

Global Cardiac Biomarker Market Research and Analysis, By Application

Global Cardiac Biomarker Market Research and Analysis, By Location of Testing

Global Cardiac Biomarker Market Research and Analysis, By Region

THE REPORTS COVERS:

Comprehensive research methodology of Global Cardiac biomarker

This report also includes detailed and extensive market overview with key analyst insights.

Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the Global Cardiac biomarker

Insights about market determinants which are stimulating the Global Cardiac biomarker

Detailed and extensive market segments with regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. REPORT SUMMARY

  • 1.1. RESEARCH METHODS AND TOOLS
  • 1.2. MARKET BREAKDOWN
    • 1.2.1. BY SEGMENTS
    • 1.2.2. BY GEOGRAPHY
    • 1.2.3. BY STAKEHOLDERS

2. MARKET OVERVIEW AND INSIGHTS

  • 2.1. DEFINITION
  • 2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
    • 2.2.1. KEY FINDINGS
    • 2.2.2. RECOMMENDATION
    • 2.2.3. CONCLUSION
  • 2.3. REGULATIONS
    • 2.3.1. UNITED STATES
    • 2.3.2. EUROPEAN UNION
    • 2.3.3. CHINA
    • 2.3.4. INDIA
    • 2.3.5. REST OF THE WORLD
  • 2.4. PATENT ANALYSIS

3. MARKET DETERMINANT

  • 3.1. MOTIVATORS
    • 3.1.1. RISING NUMBER OF CARDIOVASCULAR DISEASES
    • 3.1.2. TECHNOLOGICAL ADVANCEMENT RELATED TO BIOMARKERS
    • 3.1.3. ROBUST HEALTH CARE EXPENDITURE AND HIGH INVESTMENTS MADE FOR THE RESEARCH AND DEVELOPMENT IN DEVELOPED ECONOMIES
    • 3.1.4. URGENT NEED FOR A MORE ACCURATE FORM OF DIAGNOSIS
  • 3.2. RESTRAINTS
    • 3.2.1. HIGH CAPITAL INVESTMENTS IS REQUIRED AND PROFIT RATIO IS LOW
    • 3.2.2. STRICT GOVERNMENT RULES AND REGULATION
  • 3.3. OPPORTUNITIES
    • 3.3.1. INCREASING DEMAND OF PERSONALIZED MEDICINE
    • 3.3.2. DEVELOPMENT OF POINT OF CARE TESTING
    • 3.3.3. ADVANCEMENT IN RESEARCH AND DEVELOPMENT

4. MARKET SEGMENTATION

  • 4.1. GLOBAL CARDIAC BIOMARKER MARKET, BY TYPE
    • 4.1.1. CREATINE KINASE(CK-MB)
    • 4.1.2. TROPONINS(T,I)
    • 4.1.3. MYOGLOBIN
    • 4.1.4. NATRIURETIC PEPTIDES (BNP & NT-PROBNP)
    • 4.1.5. ISCHEMIA MODIFIED ALBUMIN
    • 4.1.6. OTHERS
  • 4.2. GLOBAL CARDIAC BIOMARKER MARKET, BY APPLICATION
    • 4.2.1. MYOCARDIAL INFRACTION
    • 4.2.2. CONGESTIVE HEART FAILURE
    • 4.2.3. ACUTE CORONARY SYNDROME
    • 4.2.4. ATHEROSCLEROSIS
    • 4.2.5. OTHERS
  • 4.3. GLOBAL CARDIAC BIOMARKER MARKET, BY LOCATION OF TESTING
    • 4.3.1. LABORATORY TESTING
    • 4.3.2. POINT OF CARE TESTING

5. COMPETITIVE LANDSCAPE

  • 5.1. STRATEGY ANALYSIS
  • 5.2. KEY COMPANY ANALYSIS

6. REGIONAL ANALYSIS

  • 6.1. NORTH AMERICA
    • 6.1.1. UNITED STATES
    • 6.1.2. CANADA
  • 6.2. EUROPE
    • 6.2.1. UNITED KINGDOM
    • 6.2.2. FRANCE
    • 6.2.3. GERMANY
    • 6.2.4. ITALY
    • 6.2.5. SPAIN
    • 6.2.6. REST OF EUROPE
  • 6.3. ASIA PACIFIC
    • 6.3.1. INDIA
    • 6.3.2. CHINA
    • 6.3.3. JAPAN
  • 6.4. REST OF THE WORLD

7. COMPANY PROFILES

  • 7.1. ABBOTT DIAGNOSTICS
  • 7.2. ALERE INC.
  • 7.3. BECTON, DICKSON & CO.
  • 7.4. BG MEDICINE INC.
  • 7.5. BIOMERIEUX
  • 7.6. BIO-RAD LABORATORIES
  • 7.7. CISBIO BIOASSAYS
  • 7.8. COVANCE
  • 7.9. CRITICAL DIAGNOSTICS
  • 7.10. LIFESIGN
  • 7.11. LUMINEX CORPORATION
  • 7.12. RANDOX LABORATORIES LTD.
  • 7.13. RESPONSE BIOMEDICAL CORPORATION
  • 7.14. ROCHE HOLDING AG
  • 7.15. SIEMENS HEALTHCARE
  • 7.16. SIGNOSIS INC.
  • 7.17. THERMO FISHER SCIENTIFIC INC.
Back to Top